Navigation Links
A Drug With Efficacy Superior to That of Remicade at Inducing Closure and Healing of Fistulas Would Earn a 30 Percent Patient Share in the Crohn's Disease Drug Market
Date:6/11/2008

and maintenance of clinical remission."

About the Report

Crohn's Disease: Physicians Seek Drugs That Treat Fistulizing Disease More Effectively than Infliximab is a DecisionBase 2008 report from Decision Resources. DecisionBase 2008 combines market forecasts with clinical and commercial end points to assess market share projections in 35 indications. These outputs are driven by quantitative and qualitative primary research. DecisionBase 2008 provides detailed market share, patient share, and price-per-day projections for emerging drugs in development. The market share projections are based on prescriber surveys that compare physicians' expectations of a potential target product profile with an emerging product profile of the leading drugs in development.

The report can be purchased by contacting Decision Resources. Members of the media may request an interview with an analyst.

About Decision Resources

Decision Resources, Inc. (http://www.decisionresources.com) is a world leader in market research publications, advisory services, and consulting designed to help clients shape strategy, allocate resources, and master their chosen markets. Decision Resources is a Decision Resources, Inc. company.

For more information, contact:

Elizabeth Marshall

Decision Resources

781-296-2563

emarshall@dresources.com


'/>"/>
SOURCE Decision Resources Inc.
Copyright©2008 PR Newswire.
All rights reserved

0

GOOD

Page: 1 2

Related medicine news :

1. USC researchers identify genetic markers that predict efficacy of novel cancer drug
2. Ohio State University Medical Center to Test Efficacy of Hyperbaric Oxygen Medicine on Stroke Victims
3. Pilot Study to Assess Safety and Efficacy of Medidur(TM) FA in AMD Patients Treated With Lucentis(R)
4. Shire investigational nonstimulant INTUNIV showed significant efficacy in reducing ADHD symptoms
5. Efficacy of FluMist(R) in Children Highlighted at Pediatric Academic Societies Meeting
6. Labopharm Appeals FDAs Decision on Once-Daily Tramadol to Next Supervisory Level After Additional Analysis Supports Efficacy
7. Gamma Secretase Modulators Show Promise in Alzheimers Disease Animal Model Efficacy Studies, According to Research Conducted by TorreyPines Therapeutics
8. Largest ever analysis of DES data demonstrates safety, efficacy in on-and-off-label use
9. GSK Data Suggests Efficacy of Advair(R) and Serevent(R) is Not Impacted by Genetic Profile
10. A Drug With Efficacy Superior to That of Memantine Would Earn up to a 50% Patient Share in the Moderate-to-Severe Alzheimers Disease Drug Market
11. What are simple ways to judge the efficacy of 5-fluorouracil in colonic neoplasm?

Post Your Comments:
*Name:
*Comment:
*Email:
(Date:11/24/2009)...FraternalOrderofPolicedistributedturkeys,cannedfoo..., PORTJERVIS,N.Y.,Nov.24/PRNewswire-USNewswire/--...shipwiththeNewYorkStateFraternalOrderofPolice,host...k,sChildDevelopmentCenter,ProjectDiscoveryinPortJe...eivefreeturkeys,ham,chickenandothertrimmingstoprov...
(Date:11/24/2009)...-Mostpeoplelookforwardtokickingofftheholidayseason...ndfamily.TheMacombCountyHealthDepartmentremindsyou...lingandbeinginlargegroupsareeasywaystospreadfluger...VACCINATION ,, Thefirstandmostimportantstepisf...insttheH1N1strainoftheflu.TheMacombCountyHealthDep...
(Date:11/24/2009)...theholidayseasonoftenbringsfamiliesandfriendstoget...hosegrievingthedeathofalovedone.Followingadeath,ev...seasoncanbringadditionalchallengestothosewhoaregri...vingChildren,AdolescentsandTheirFamilies,isavailab...yofprintandonlineresourcesavailabletohelpchildreng...
(Date:11/24/2009)...ionLaborLifeInsuranceCompany("UnionLaborLife")anno...ion,slargestvisionbenefitsandservicescompany,topro...rustfunds,unionemployersandtheirmembers. ,, VSP...ngcomprehensiveeyeexams,broadselectionsofopticalfr...eis,"statedBruceSmith,NationalSales,VSP."Comprehen...
(Date:11/24/2009)...too loud, or contain dangerous chemicals , ...oliday shopping season begins, parents need to kno... stores across the United States. , That,s the ... report, released Tuesday by the U.S. Public Inter... on toys that pose a choking hazard, are excessive...
Breaking Medicine News(10 mins):Health News:Fraternal Order of Police Provides Food and Hope for Families in Port Jervis this Thanksgiving 2Health News:Tips To Enjoy a Flu-Free Holiday Season 2Health News:Highmark Caring Place Resources Help Children and Families Who Are Grieving During the Holidays 2Health News:Union Labor Life & VSP Vision Care Align to Offer Vision Insurance Products 2Health News:Dangerous Toys Still on Store Shelves, Report Finds 2Health News:Dangerous Toys Still on Store Shelves, Report Finds 3
...study, published in the June 6 issue of JAMA, has ...itary diffuse gastric cancer. It states that thes... events and common ancestry. The study has been re...ormation in the article, gastric cancer is the sec...
...SHINGTON, DC A new study published in the journal ...ssociation (APA), states that young adults with a ...promised lung function. The condition persisted ev...ur metropolitan areas (sampled from the Coronary A...
...ICAGO, A five-year follow-up of National Surgical...-31, presented at the annual meeting of the Americ... states that the risk of congestive heart failure ...rch team developed a prediction model based on the...
...ICAGO Findings presented today at the American So...alanis, M.D., a Mayo Clinic oncologist, reveals th...ws activity in patients with recurrent glioblastom... lead investigator of the study. Glioblast...
...itical care, emergency service and intensive care ... Rs.300 million boost from its new owner Fortis He....300 million) in Escorts within two years," Fortis...ot getting the desired focus for the last 20 month...
...cistm does upset those at the receiving end, even ...al slights and ambiguous remarks that are hard to ...overt discrimination, according to a study of 180 ...mptoms of depression and anxiety," said lead autho...
Other Medicine News:Health News:Researchers Identify Genetic Mutations for Hereditary Diffuse Gastric Cancer 2Health News:Researchers Identify Genetic Mutations for Hereditary Diffuse Gastric Cancer 3Health News:Unhealthy Lungs Linked to Hostility? 2Health News:Long-term Use of Herceptin Does Not Increase Heart Failure in Patients 2Health News:Recurrent Gliomas: Vorinostat Shows Anti-cancer Activity 2Health News:Fortis to Inject Rs.300 Mn into Escorts Hospital 2Health News:Koreans in Canada Feel Put Down by Subtle Racism 2
(Date:11/24/2009)...ANDIEGO,Nov.24/PRNewswire-FirstCall/--OptimerPharm...atthe21stAnnualPiperJaffrayHealthCareConferenceatT...p.m.EasternTime. ,, (Logo: http://www.newscom.c...audiowebcastofthispresentationwillbeaccessibleonth...pharma.com .Replaysofthispresentationwillbeavaila...
(Date:11/24/2009)...EWYORK,Nov.24/PRNewswire-FirstCall/--KeryxBiopharm...nBentsur,theCompany,sChiefExecutiveOfficer,issched...ConferencebeingheldinNewYorkCity. ,, Mr.Bentsur...r2ndat10:30AMETandwillbeaccessiblefromtheInvestorI...tors.keryx.com .Anarchivedversionofthewebcastwillb...
(Date:11/24/2009)...YNBROOK,N.Y.,Nov.24/PRNewswire-FirstCall/--BioSpec...uticalcompanydevelopingfirstinclasscollagenase-bas...t,TomWegman,willpresentattheupcomingPiperJaffray21...09,at3:30pmETatTheNewYorkPalaceHotelinNewYork,NY. ...der"CalendarofEvents"intheInvestorRelationssection...
Breaking Medicine Technology:Keryx Biopharmaceuticals to Present at the Piper Jaffray 21st Annual Health Care Conference 2Minorities have poorer results higher rates of inappropriate surgery to prevent stroke 55308 1Minorities have poorer results higher rates of inappropriate surgery to prevent stroke 55308 2Ellison Medical Foundation awards more than 241 million to mid career scientists 55303 1Ellison Medical Foundation awards more than 241 million to mid career scientists 55303 2New Data Show ChloraPrep 28R 29 Significantly More Effective Than DuraPrep 28TM 29 and Povidone Iodine in Eliminating Bacteria From Skin Prior to Shou 55300 1New Data Show ChloraPrep 28R 29 Significantly More Effective Than DuraPrep 28TM 29 and Povidone Iodine in Eliminating Bacteria From Skin Prior to Shou 55300 2New Data Show ChloraPrep 28R 29 Significantly More Effective Than DuraPrep 28TM 29 and Povidone Iodine in Eliminating Bacteria From Skin Prior to Shou 55300 3New Data Show ChloraPrep 28R 29 Significantly More Effective Than DuraPrep 28TM 29 and Povidone Iodine in Eliminating Bacteria From Skin Prior to Shou 55300 4New Data Show ChloraPrep 28R 29 Significantly More Effective Than DuraPrep 28TM 29 and Povidone Iodine in Eliminating Bacteria From Skin Prior to Shou 55300 5
...sdaq: IOMI ) today announced that Stanley C. Erck...cer, will present at the Acumen BioFin,Rodman & Re... City on,Monday, Nov. 5. Mr. Erck,s presentation w... I Room of the New York Palace Hotel. Mr. Erck,s ...tch-based,needle-free vaccines and immunostimulant...
...alled POLI 1 -, BOSTON, Nov. 2 R1626, one of Roc...is C virus (HCV) infection, has,shown promising an...GASYS(R) (peginterferon alfa-2a) and COPEGUS(TM) (...t the American Association for the Study of the,Li... Nov. 2-6. After four,weeks of treatment with this...
Other Medicine Technology:Iomai CEO to Speak at Acumen BioFin Rodman & Renshaw Annual Healthcare Conference on Monday, Nov. 5 2Roche's Investigational Polymerase Inhibitor, Combined with PEGASYS(R) and COPEGUS(TM), Shows Potent Antiviral Activity in Treatment of Chronic Hepatitis C at Four Weeks 2Roche's Investigational Polymerase Inhibitor, Combined with PEGASYS(R) and COPEGUS(TM), Shows Potent Antiviral Activity in Treatment of Chronic Hepatitis C at Four Weeks 3Roche's Investigational Polymerase Inhibitor, Combined with PEGASYS(R) and COPEGUS(TM), Shows Potent Antiviral Activity in Treatment of Chronic Hepatitis C at Four Weeks 4Roche's Investigational Polymerase Inhibitor, Combined with PEGASYS(R) and COPEGUS(TM), Shows Potent Antiviral Activity in Treatment of Chronic Hepatitis C at Four Weeks 5Roche's Investigational Polymerase Inhibitor, Combined with PEGASYS(R) and COPEGUS(TM), Shows Potent Antiviral Activity in Treatment of Chronic Hepatitis C at Four Weeks 6Roche's Investigational Polymerase Inhibitor, Combined with PEGASYS(R) and COPEGUS(TM), Shows Potent Antiviral Activity in Treatment of Chronic Hepatitis C at Four Weeks 7
Kremer Angled Fixation Forceps
...nsworth 100 Hue Test including MS-Excel scoring te... Farnsworth 100 Hue Test comes boxed in clear acry... the potential for test disruption by holding the... test from Richmond Products includes 93 color dis...
Farnsworth's D15 Test
... 4th edition pseudoisochromatic test from Richmond...the six screener plates and the 14 diagnostic seri...has its own tab for easy and clean page selection....nglish and a laminated copy of the score sheet. Th...
Medicine Products: